Kate E Brain
Overview
Explore the profile of Kate E Brain including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
526
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quinn-Scoggins H, Murray R, Quaife S, Smith P, Brain K, Callister M, et al.
BMC Pulm Med
. 2022 Dec;
22(1):478.
PMID: 36522781
Background: Optimising smoking cessation services within a low radiation-dose computed tomography (LDCT) lung cancer screening programme has the potential to improve cost-effectiveness and overall efficacy of the programme. However, evidence...
2.
Jallow M, Black G, Van Os S, Baldwin D, Brain K, Donnelly M, et al.
Health Expect
. 2022 Apr;
25(4):1776-1788.
PMID: 35475542
Background: Many countries are introducing low-dose computed tomography screening programmes for people at high risk of lung cancer. Effective communication strategies that convey risks and benefits, including unfamiliar concepts and...
3.
Jallow M, Bonfield S, Kurtidu C, Baldwin D, Black G, Brain K, et al.
Chest
. 2021 Dec;
162(4):930-941.
PMID: 34922933
Several countries mandate informed or shared decision-making for low-dose CT (LDCT) lung cancer screening, but knowledge is limited about the type of information and presentation techniques used to support decision-making...
4.
Field J, Vulkan D, Davies M, Baldwin D, Brain K, Devaraj A, et al.
Lancet Reg Health Eur
. 2021 Nov;
10:100179.
PMID: 34806061
Background: The NLST reported a significant 20% reduction in lung cancer mortality with three annual low-dose CT (LDCT) screens and the Dutch-Belgian NELSON trial indicates a similar reduction. We present...
5.
Quaife S, Waller J, Dickson J, Brain K, Kurtidu C, McCabe J, et al.
J Thorac Oncol
. 2021 Aug;
16(12):2016-2028.
PMID: 34403828
Introduction: Low uptake of low-dose computed tomography lung cancer screening by high-risk groups compromises its effectiveness and equity as a population-level early detection strategy. Numerous psychological factors are implicated qualitatively...
6.
Quaife S, Janes S, Brain K
Transl Lung Cancer Res
. 2021 Jun;
10(5):2427-2440.
PMID: 34164290
Lung cancer is the leading cause of cancer mortality globally, responsible for an estimated 1.76 million deaths worldwide in 2018 alone. Screening adults at high risk of lung cancer using...
7.
Quaife S, Brain K, Stevens C, Kurtidu C, Janes S, Waller J
Psychol Health
. 2021 Feb;
37(2):194-210.
PMID: 33593154
Background: Research implicates psychological factors in low uptake of lung cancer screening. We developed and psychometrically tested a standardised measure of these psychological determinants in preparation for a prospective, longitudinal...
8.
Smits S, McCutchan G, Hanson J, Brain K
Health Expect
. 2018 Aug;
21(6):1150-1158.
PMID: 30085384
Background: Lung cancer is the leading cause of cancer death worldwide. Routine UK lung cancer screening is not yet available, thus understanding barriers to participation in lung screening could help...
9.
Field J, Duffy S, Baldwin D, Brain K, Devaraj A, Eisen T, et al.
Health Technol Assess
. 2016 May;
20(40):1-146.
PMID: 27224642
Background: Lung cancer kills more people than any other cancer in the UK (5-year survival < 13%). Early diagnosis can save lives. The USA-based National Lung Cancer Screening Trial reported...
10.
McCutchan G, Wood F, Edwards A, Richards R, Brain K
BMC Cancer
. 2015 Dec;
15:1000.
PMID: 26698112
Background: People from lower socioeconomic groups have worse survival outcomes for cancer, which in part reflects later-stage disease at diagnosis. The mechanisms underlying delayed cancer symptom presentation in lower socioeconomic...